Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Jinhong Pharmaceutical is a comprehensive pharmaceutical enterprise based in China, primarily engaged in the research, production, and sale of chemical active pharmaceutical ingredients (APIs) and finished drug products. Established in 1992, the company has developed a robust portfolio centered on anti-infective agents, cardiovascular medications, and gastrointestinal therapies. Its manufacturing facilities are GMP-certified, supporting the production of various dosage forms including tablets, capsules, and granules. Jinhong Pharmaceutical is recognized for its integration of API synthesis with finished product manufacturing, enhancing its competitiveness in the generic drug market. The company serves a broad customer base across China and exports products to several international regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jinhong Pharmaceutical.